Phase 4
Completed N=50
Benzac 5% Gel in Combination With Cosmetic Products in Acne Vulgaris
Source: ClinicalTrials.gov NCT02589405 ↗Enrolled (actual)
50
Serious AEs
2.0%
Results posted
Feb 2019
Primary outcomePrimary: Number of Participants Satisfied and Very Satisfied With Regimen — 42 participants
◆ Published Evidence
Emerging
10citations · ~1 / year
Combination of benzoyl peroxide 5% gel with liquid cleanser and moisturizer SPF 30 in acne treatment results in high levels of subject satisfaction, good adherence and favorable tolerability.
Summary
The aim of this study is to evaluate a complete acne regimen consisting of a medication (Benzaknen® 5% Gel), and 2 cosmetic products Dermotivin® Soft Liquid soap and Cetaphil® Dermacontrol Moisturizer SPF30 in patients with acne.
Linked Publications
-
Combination of benzoyl peroxide 5% gel with liquid cleanser and moisturizer SPF 30 in acne treatment results in high levels of subject satisfaction, good adherence and favorable tolerability.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants Satisfied and Very Satisfied With Regimen |
42 | — |
Eligibility Criteria
Inclusion Criteria
- Male or female subject of any ethnic background of 12 years or older.
- Subject with mild or moderate facial acne vulgaris defined as an Investigator Global Assessment (IGA) score at 2 or 3 on a 0-4 scale.
- Subject with any skin phototype according to T.B. Fitzpatrick skin phototype definitions.
Exclusion Criteria
- Subject with severe acne (IGA>3) with nodules, cysts, scars or extra-facial lesions,
- Female subject who is pregnant, lactating or planning a pregnancy during the study,
- Subject susceptible to take a corticosteroid treatment during the study except inhaled or topic when needed to treat a condition outside the face,
Data sourced from ClinicalTrials.gov (NCT02589405) and the linked publication. Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.